Diagnostic accuracy of level 3 portable sleep tests versus level 1 polysomnography for sleep-disordered breathing: a systematic review and meta-analysis

被引:153
作者
El Shayeb, Mohamed [1 ]
Topfer, Leigh-Ann [1 ]
Stafinski, Tania [1 ]
Pawluk, Lawrence [2 ]
Menon, Devidas [1 ]
机构
[1] Univ Alberta, Dept Psychiat, Sch Publ Hlth, Hlth Technol & Policy Unit, Edmonton, AB, Canada
[2] Univ Alberta, Dept Psychiat, Sleep Med Program, Edmonton, AB, Canada
关键词
HOME RESPIRATORY POLYGRAPHY; HEALTH-CARE UTILIZATION; APNEA SYNDROME; AMBULATORY DEVICE; HYPOPNEA SYNDROME; VALIDATION; MANAGEMENT; RISK; MONITOR; HETEROGENEITY;
D O I
10.1503/cmaj.130952
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Greater awareness of sleep-disordered breathing and rising obesity rates have fueled demand for sleep studies. Sleep testing using level 3 portable devices may expedite diagnosis and reduce the costs associated with level 1 in-laboratory polysomnography. We sought to assess the diagnostic accuracy of level 3 testing compared with level 1 testing and to identify the appropriate patient population for each test. Methods: We conducted a systematic review and meta-analysis of comparative studies of level 3 versus level 1 sleep tests in adults with suspected sleep-disordered breathing. We searched 3 research databases and grey literature sources for studies that reported on diagnostic accuracy parameters or disease management after diagnosis. Two reviewers screened the search results, selected potentially relevant studies and extracted data. We used a bivariate mixed-effects binary regression model to estimate summary diagnostic accuracy parameters. Results: We included 59 studies involving a total of 5026 evaluable patients (mostly patients suspected of having obstructive sleep apnea). Of these, 19 studies were included in the meta-analysis. The estimated area under the receiver operating characteristics curve was high, ranging between 0.85 and 0.99 across different levels of disease severity. Summary sensitivity ranged between 0.79 and 0.97, and summary specificity ranged between 0.60 and 0.93 across different apnea-hypopnea cut-offs. We saw no significant difference in the clinical management parameters between patients who underwent either test to receive their diagnosis. Interpretation: Level 3 portable devices showed good diagnostic performance compared with level 1 sleep tests in adult patients with a high pretest probability of moderate to severe obstructive sleep apnea and no unstable comorbidities. For patients suspected of having other types of sleep-disordered breathing or sleep disorders not related to breathing, level 1 testing remains the reference standard.
引用
收藏
页码:E25 / E51
页数:27
相关论文
共 116 条
  • [1] Abraham William T, 2006, Congest Heart Fail, V12, P241, DOI 10.1111/j.1527-5299.2006.05693.x
  • [2] Emerging Therapies for Obstructive Sleep Apnea
    Akinnusi, Morohunfolu
    Saliba, Ranime
    El-Solh, Ali A.
    [J]. LUNG, 2012, 190 (04) : 365 - 371
  • [3] Aksenov IV, 2009, SLEEP, V32, pA183
  • [4] The economic impact of obstructive sleep apnea
    AlGhanim, Nayef
    Comondore, Vikram R.
    Fleetham, John
    Marra, Carlo A.
    Ayas, Najib T.
    [J]. LUNG, 2008, 186 (01) : 7 - 12
  • [5] Amir O, 2010, J CLIN SLEEP MED, V6, P59
  • [6] Effect of an ambulatory diagnostic and treatment programme in patients with sleep apnoea
    Andreu, A. L.
    Chiner, E.
    Sancho-Chust, J. N.
    Pastor, E.
    Llombart, M.
    Gomez-Merino, E.
    Senent, C.
    Barbe, F.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2012, 39 (02) : 305 - 312
  • [7] Canadian Thoracic Society 2011 guideline update: Diagnosis and treatment of sleep disordered breathing
    不详
    [J]. CANADIAN RESPIRATORY JOURNAL, 2011, 18 (01) : 25 - 47
  • [8] [Anonymous], PORTABLE DEVICES USE
  • [9] [Anonymous], DIAGN TREATM OBSTR S
  • [10] [Anonymous], SLEEP BIOL RHYTHM S